AYTU
AYTU BIOPHARMA, INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$2.12
+6.00%Forward multiples
Based on analyst estimates
- P/E forward
- 8.48x
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1.96x
- P/S forward
- 0.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.65x
- Price / sales
- 0.40x
- Price / cash flow
- 13.56x
Enterprise value
- Enterprise value
- $19.0M
- EV / sales
- 0.34x
- EV / EBITDA
- -0.69x
- EV / EBIT
- -1.25x
- Market cap
- $22.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026